Findings from human studies are also inconsistent, since circulating TRAIL levels were either lower in NASH compared to hepatic steatosis in a small study of biopsy-proven NASH [36] or higher in NAFLD compared to controls in another study, which however did not specify the method of NAFLD diagnosis [37]. Here, TNFSF10 is linked to metabolic dysfunction-associated steatotic liver disease.